Similar Papers

Paper Title
Journal
Date
Author
Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR/ACR/PRINTO classification criteria.
Sung Soo Ahn ... Min-Chan Park
PLOS ONE | VOL. 14
Sung Soo Ahn, et. al.Sung Soo Ahn ... Min-Chan Park
18 Jul 2019
AB1345 Evaluation of macrophage activation syndrome in hospitalised febrile patients with kikuchi-fujimoto disease based on the 2016 eular/acr/printo classification criteria
S.S Ahn ... S.M Jung
Annals of the Rheumatic Diseases | VOL. 77
S.S Ahn, et. al.S.S Ahn ... S.M Jung
01 Jun 2018
Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
Tomoka Hiyama ... Satoko Arai
Clinical and experimental medicine | VOL. 23
Tomoka Hiyama, et. al.Tomoka Hiyama ... Satoko Arai
07 Jan 2023
Unremitting pyrexia, pancytopenia, hepatosplenomegaly, and extreme hyperferritinemia
Harinder Gill ... Chak‐Sing Lau
American Journal of Hematology | VOL. 88
Harinder Gill, et. al.Harinder Gill ... Chak‐Sing Lau
30 May 2013
View more papers

More From: Rheumatology Advances in Practice

Paper Title
Journal
Date
Author
Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
Hajime Yoshifuji ... Yoshikazu Nakaoka
Rheumatology Advances in Practice | VOL. -
Hajime Yoshifuji, et. al.Hajime Yoshifuji ... Yoshikazu Nakaoka
03 Feb 2025
BASDAI and ASDAS disease states in relationship to ASAS40 response: post-hoc analysis of ixekizumab in radiographic axial spondyloarthritis
Martin Rudwaleit ... Jean Dudler
Rheumatology Advances in Practice | VOL. -
Martin Rudwaleit, et. al.Martin Rudwaleit ... Jean Dudler
29 Jan 2025
Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysis
Dafna D Gladman ... Peter Nash
Rheumatology Advances in Practice | VOL. -
Dafna D Gladman, et. al.Dafna D Gladman ... Peter Nash
21 Jan 2025
Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysis
Dafna D Gladman ... Peter Nash
Rheumatology Advances in Practice | VOL. -
Dafna D Gladman, et. al.Dafna D Gladman ... Peter Nash
21 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.